Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda

Journal of the International AIDS Society

Volumn 14, Issue 1, 2011, Pages

  Mills, Edward J ^a,b   Bakanda, Celestin ^c   Birungi, Josephine ^c   Chan, Keith ^b   Hogg, Robert S ^b   Ford, Nathan ^d   Nachega, Jean B ^e,f   Cooper, Curtis L ^g  

^a UNIVERSITY OF OTTAWA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c THE AIDS SUPPORT ORGANIZATION   (Uganda)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; STAVUDINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; UGANDA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE AGED; SURVIVAL;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SURVIVAL ANALYSIS; UGANDA; YOUNG ADULT;

EID: 80155193081     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-14-52     Document Type: Article

References (31)

1. World Health Organization (WHO), HIV/AIDS epidemiological surveillance report for the WHO African Region, 2007 update World Health Organization, Regional Office for Africa 2008
2. United Nations Integrated Regional Information Networks, Uganda: Men's union encourages men to be more open about HIV United Nations Integrated Regional Information Networks 2006 22050673
3. African women and AIDS: negotiating behavioral change. Ulin PR, Soc Sci Med 1992 34 63 73 10.1016/0277-9536(92)90068-2 1738858
4. Expanding HIV care in Africa: making men matter. Mills EJ, Ford N, Mugyenyi P, Lancet 2009 374 275 276 10.1016/S0140-6736(09)61348-9 19632481
5. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N, Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group, J Womens Health 2008 17 47 55 10.1089/jwh.2007.0353 (Pubitemid 351197536)
6. Sex differences in antiretroviral treatment outcomes among HIV-infected adults in an urban Tanzanian setting. Hawkins C, Chalamilla G, Okuma J, Spiegelman D, Hertzmark E, Aris E, Ewald T, Mugusi F, Mtasiwa D, Fawzi W, AIDS 2011 25 1189 1197 10.1097/QAD.0b013e3283471deb 21505309
7. Can we increase male involvement in AIDS treatment? Birungi J, Mills EJ, Lancet 2010 376 1302 20951892
8. Expanding HIV care in Africa: making men matter in Johannesburg. Kuwane B, Appiah K, Felix M, Grant A, Churchyard G, Lancet 2009 374 1329 19837252
9. Are men the losers of the antiretroviral treatment scale-up? Johannessen A, AIDS 2011 25 1225 1226 10.1097/QAD.0b013e32834403b8 21593620
10. Gender and HIV/AIDS: What Do Men have to Do with it? Mane P, Aggleton P, Current Sociology 2001 49 23 37
11. Cohort Profile: The TASO-CAN Cohort Collaboration. Bakanda C, Birungi J, Nkoyooyo A, Featherstone A, Cooper CL, Hogg RS, Mills EJ, Int J Epidemiol 2011
12. Uganda Ministry of Health, National Antiretroviral Treatment and Care Guidelines for Adults, Adolescents and Children 2009
13. World Health Organization (WHO), WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-related Disease in Adults and Children 2008
14. Combination antiretroviral therapy in population affected by conflict: outcomes from large cohort in northern Uganda. Kiboneka A, Nyatia RJ, Nabiryo C, Anema A, Cooper CL, Fernandes KA, Montaner JS, Mills EJ, BMJ 2009 338 2662 10.1136/bmj.a2662 19224964
15. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP, MacPhail P, van Cutsem G, Messou E, Wood R, Nash D, Pascoe M, Dickinson D, Etard JF, McIntyre JA, Brinkhof MW, IeDEA East Africa, West Africa and Southern Africa, PLoS Med 2011 8 1000390 10.1371/journal.pmed.1000390 21267057
16. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, Coutinho A, Jaffar S, BMC Public Health 2009 9 290 10.1186/1471-2458-9-290 19671185
17. Multiple Imputation for Missing Data: concepts and New Development. Yuan YC, SAS Code http://support.sas.com/rnd/app/papers/multipleimputation.pdf
18. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M, IeDEA Southern Africa and West Africa, Lancet 2010 376 449 457 10.1016/S0140-6736(10)60666-6 20638120
19. The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Cornell M, Myer L, Kaplan R, Bekker LG, Wood R, Trop Med Int Health 2009 14 722 731 10.1111/j.1365-3156.2009.02290.x 19413745
20. Increased mortality of male adults with AIDS related to poor compliance to antiretroviral therapy in Malawi. Chen SC, Yu JK, Harries AD, Bong CN, Kolola-Dzimadzi R, Tok TS, King CC, Wang JD, Trop Med Int Health 2008 13 513 519 10.1111/j.1365-3156.2008.02029.x 18282238 (Pubitemid 351533602)
21. Ten myths and one truth about generalised HIV epidemics. Shelton JD, Lancet 2007 370 1809 1811 10.1016/S0140-6736(07)61755-3 18061042 (Pubitemid 350186050)
22. Chant SH, Gutmann MC, Mainstreaming men into gender and development: Debates, reflections, and experiences Oxfam 2000
23. Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda. Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, Joffres M, Anema A, Cooper CL, Montaner JS, Mills EJ, AIDS 2008 22 2493 2499 10.1097/QAD.0b013e328318f148 19005272
24. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N, Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group, J Womens Health (Larchmt) 2008 17 47 55 10.1089/jwh.2007.0353 (Pubitemid 351197536)
25. Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Taylor-Smith K, Tweya H, Harries A, Schoutene E, Jahn A, Malawi Medical Journal 2010 22 49 56 21614882
26. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul M, Hogg RS, Ann Intern Med 2011 155 209 216 21768555
27. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. Rosen S, Fox MP, Gill CJ, PLoS Med 2007 4 298 10.1371/journal.pmed.0040298 17941716 (Pubitemid 350035458)
28. Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review. Rosen S, Fox MP, PLoS Med 2011 8 1001056 10.1371/journal.pmed.1001056 21811403
29. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. Muula AS, Ngulube TJ, Siziya S, Makupe CM, Umar E, Prozesky HW, Wiysonge CS, Mataya RH, BMC Public Health 2007 7 63 10.1186/1471-2458-7-63 17459154 (Pubitemid 46761475)
30. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke GS, Newell ML, Bull World Health Organ 2010 88 593 600 10.2471/BLT.09.069419 20680124
31. Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response. Melekhin VV, Shepherd BE, Stinnette SE, Rebeiro PF, Barkanic G, Raffanti SP, Sterling TR, PLoS One 2009 4 6961 10.1371/journal.pone.0006961 19742315